GeekWire

JULY 15, 2021

Sana Biotechnology , a young and fast-growing Seattle-based biotech, has chosen the San Francisco Bay Area as the site for its new biomanufacturing facility. Competition for researchers skilled in biomanufacturing and other areas can be stiff, and the Bay Area is a much larger, more established biotechnology hub than Seattle.

Biotechnology 114

Biotechnology Development Construction Advertising 114

GeekWire

OCTOBER 10, 2023

Sana Biotechnology will reduce its workforce by 29%, the Seattle-based cell and gene therapy company revealed in a SEC filing Tuesday. The company said it is increasing focus on its ex vivo cell therapy product candidates, resulting in a “strategic re-positioning” and delaying other projects.

Biotechnology 106

Biotechnology .Net Report Company 106

GeekWire

FEBRUARY 1, 2021

Adaptive Biotechnologies). Adaptive Biotechnologies has promoted one exec, while another is departing next month. Adaptive Biotechnologies’ EVP of Operations and Management Nancy Hill will depart the company in March. Bevier joined the F5 board in 2006. Mark Adams. Mark Adams is now COO.

Biotechnology 117

Biotechnology Fractional CTO CTO Hire Financial 117

GeekWire

FEBRUARY 8, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology , a Seattle-based biotech startup led by Isilon co-founder Sujal Patel , is the latest company to go public using a special purpose acquisition company, or SPAC. Nautilus Photo).

Biotechnology 145

Biotechnology .Net Groups Company 145

GeekWire

OCTOBER 19, 2021

Sana Biotechnology has a new $50 million tool in its toolbox. Sana CEO and president Steve Harr. Sana Photo). Sana signed an agreement with Beam Therapeutics for non-exclusive commercial rights to the Cambridge, Mass.-based based biotech’s gene editing system, called CRISPR-Cas12b.

Biotechnology 135

Biotechnology System Programming Engineering 135

GeekWire

NOVEMBER 30, 2022

Seattle-based cell and gene therapy company Sana Biotechnology will reduce its workforce by 15%, according to a statement issued Tuesday. Adaptive Biotechnologies , Absci , and Zymeworks also announced layoffs this year. Sana CEO Steve Harr. Sana Photo). Seattle startup TwinStrand Biosciences also reportedly laid off staff.

Biotechnology 107

Biotechnology Company Programming Financial 107

GeekWire

JUNE 9, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

Biotechnology 131

Biotechnology Analysis Research Engineering 131

GeekWire

AUGUST 12, 2024

A biotech prize for turning chemicals into food On the biotechnology front, the Mars Society plans to offer an incentive prize for methods that use microbes to convert simple chemicals, such as methane or methanol, into food. “Ask it anything you want, and you get the answer in multiple personalities,” he said.

Biotechnology 128

Biotechnology Chemicals Artificial Intelligence Engineering 128

GeekWire

NOVEMBER 10, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies beat expectations for its fiscal third quarter as the Seattle company continues to use its immune medicine platform in the fight against COVID-19. GeekWire Photo). Adaptive posted revenue of $26.3 million, up 1% year-over-year, and earnings per share of -$0.27.

Biotechnology 86

Biotechnology Pharmaceuticals Development System 86

GeekWire

JULY 14, 2020

Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help accelerate the company’s work.

Biotechnology 78

Biotechnology Development Microsoft Report 78

GeekWire

JULY 27, 2020

Chad Robins, CEO of Adaptive Biotechnologies, speaks at the site of the company’s future corporate headquarters in Seattle, standing in front of the final piece of structural steel before it’s put into place. Stephen Brashear/AP Images for Adaptive Biotechnologies). Stephen Brashear/AP Images for Adaptive Biotechnologies).

Biotechnology 135

Biotechnology Real Estate Industry Microsoft 135

Tech Republic Big Data

DECEMBER 26, 2016

As interesting as big data can be in Silicon Valley, its most fascinating applications often happen elsewhere.

Big Data 111

Big Data Biotechnology Data Applications 111

GeekWire

APRIL 15, 2021

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

Biotechnology 111

Biotechnology Education Web Services Insurance 111

GeekWire

JULY 8, 2021

Absci is the latest in a string of Washington state biotech startups to test the public markets — others including Impel Neuropharma, Sana Biotechnology, Athira Pharma, and Silverback Therapeutics have had IPOs in the past year. The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Alexandre.

Biotechnology 133

Biotechnology Industry Real Estate Company 133

GeekWire

JULY 2, 2020

OncoSenX is the spinoff of a third company, Seattle-based Oisin Biotechnologies. The researchers said they have selected the two most promising DNA sequences for further testing. Researchers at OncoSenX are using Fusogenix for cancer research on the treatment of solid tumors.

Research 145

Research Pharmaceuticals Biotechnology Development 145

TechSpot

JULY 24, 2024

The UK Space Agency and BiologIC Technologies are partnering to develop advanced biotechnologies, including vaccines and gene therapies, for space manufacturing.

Biotechnology 111

Biotechnology Research Development 111

GeekWire

SEPTEMBER 26, 2024

Nautilus Biotechnology Photo) — After more than two decades at scientific instruments company Agilent Technologies, Ken Suzuki is now chief marketing officer for Nautilus Biotechnology. ” Ken Suzuki. Seattle-based Nautilus has designed a platform for analyzing proteomes, a term for the proteins produced by an organism.

CTO 111

CTO Healthcare Biotechnology Nonprofit 111

GeekWire

MAY 11, 2020

OncoSenX is a spinout out of Oisin Biotechnologies, a 5-year-old Seattle company also led by Scholz, a veteran biotech entrepreneur. The Seattle-based company just extended its oversubscribed SAFE (Simple Agreement for Future Equity) to allow for more capital, confirmed CEO Matthew Scholz. million to date.

Biotechnology 142

Biotechnology System Company 142

GeekWire

JULY 29, 2021

The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Leslie Alexandre, CEO of Life Sciences Washington. Biotech IPOs reached an all-time high last year, according to Biopharma Dive , and the pace is continuing into 2021.

Biotechnology 140

Biotechnology Company Pharmaceuticals Research 140

CIO Business Intelligence

JANUARY 2, 2024

That’s the case for Yi Zhou, CTO and CIO with Adaptive Biotechnologies. In today’s dynamic business environment, IT must transcend traditional roles,” Adaptive Biotechnologies’ Zhou says. He plans to scale his company’s experimental generative AI initiatives “and evolve into an AI-native enterprise” in 2024.

Biotechnology 361

Biotechnology Fractional CTO Agile Security 361

GeekWire

NOVEMBER 13, 2020

Adaptive Biotechnologies says it’s proceeding with plans to launch a new type of test to determine if someone was previously infected with SARS-CoV-2, the virus that causes COVID-19, after a study added to the evidence that its approach is more accurate than currently available antibody tests. Adaptive Biotechnologies Photo).

Biotechnology 138

Biotechnology Study Comparison .Net 138

GeekWire

NOVEMBER 19, 2020

Others include Sana Biotechnology, Chinook Therapeutics, Kineta, Alpine Immune Sciences, Adaptive Biotechnologies, and more, in addition to work being done at Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Benaroya Research Institute, and others.

Biotechnology 145

Biotechnology Research CTO Development 145

GeekWire

JUNE 30, 2021

The company, founded in 2011, began commercial operations in 2018 and now has partnerships with Merck, Xyphos Biotechnology, Alpha Cancer Technologies and several other drug companies. Three Washington state companies — Sana Biotechnology , Impel Neuropharma and Paymentus — have gone public with a traditional IPO this year.

Company 133

Company Biotechnology .Net Programming 133

CIO Business Intelligence

JUNE 2, 2022

The work, led by Professor Ross King from the University of Cambridge Department of Chemical Engineering and Biotechnology, teaches computers to learn more like how humans do—by building on what’s been learned in the past. .

Dell 355

Dell Intel Artificial Intelligence Energy 355

CIO Business Intelligence

MAY 31, 2022

This is the first such incubator, funded by the government’s Department of Biotechnology, to be set up in a medical college,” claims Rath. “Till now, such incubators were set up by the government in IITs and other engineering colleges.

Healthcare 287

Healthcare Biotechnology Artificial Intelligence Research 287

GeekWire

FEBRUARY 26, 2021

This was a first-of-its kind diagnostic tool from Seattle-based Adaptive Biotechnologies , a company that develops technology to sequence the human immune system for the diagnosis and treatment of disease. Adaptive Biotechnologies’ new test, called T-Detect COVID , was developed in partnership with Microsoft.

Biotechnology 140

Biotechnology System Study Development 140

GeekWire

JANUARY 14, 2022

The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday. government has been buying to fight Omicron.

Biotechnology 107

Biotechnology Government Research Development 107

GeekWire

FEBRUARY 11, 2021

Spinout success: Other Fred Hutch spinouts include Juno Therapeutics and Adaptive Biotechnologies, while University of Washington research led to the launch of Icosavax, Neoleukin Therapeutics, Universal Cells, Cyrus Biotechnology and others.

Biotechnology 140

Biotechnology Research Healthcare Engineering 140

GeekWire

MAY 12, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue , to nearly $21 million. GeekWire File Photo). The Seattle-based company posted a net loss of $31.4

Biotechnology 114

Biotechnology Pharmaceuticals .Net Microsoft 114

GeekWire

JUNE 10, 2021

This week Seattle-based Nautilus Biotechnology, led by Isilon Systems co-founder Sujal Patel, went public via a SPAC merger. Remitly, ranked No. 3 on the GeekWire 200 list of top Pacific Northwest tech startups, has around 1,000 employees across its Seattle HQ and six other offices in Spokane, Wash.,

Company 143

Company Biotechnology Banking Mobile 143

CTOvision

APRIL 29, 2016

ASU researcher improves crop performance with new biotechnology (eurekalert.org). Find more information on ASU's usage of HDP™ to further cancer research here. Find more information on Hortonworks here. Related articles. Analyzing Twitter: Advanced Algorithm Predicts Likelihood of Online Protests (cacm.acm.org). Today is National DNA Day!

Biotechnology 150

Biotechnology Data Research Education 150

GeekWire

JULY 7, 2021

Pacific Northwest biotechs that have gone public this year include Sana Biotechnology, which raised $587 million in its February IPO and Impel NeuroPharma, which raised $80 million through its IPO in April.

Development 142

Development Biotechnology Pharmaceuticals .Net 142

GeekWire

APRIL 16, 2021

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Adaptive Biotechnologies. So it’s little wonder that there’s stiff competition for the 2021 GeekWire Health Innovation of the Year.

Biotechnology 122

Biotechnology Virtualization Healthcare Artificial Intelligence 122

GeekWire

SEPTEMBER 17, 2020

Formerly known as M3 Biotechnology, the company is led by Dr. Leen Kawas , a 35-year-old CEO who will be the first woman to guide a company to an initial public offering in Washington state in more than two decades. It is the first Seattle biotech to go public since Adaptive Biotechnologies IPO’d last year.

Biotechnology 126

Biotechnology .Net Company Report 126

GeekWire

SEPTEMBER 1, 2020

Lumen is led by Finrow, a former senior vice president at Adaptive Biotechnologies, and Chief Science Officer Jim Roberts , the former head of basic sciences at the Fred Hutchinson Cancer Research Institute. They co-founded the startup in 2017.

Development 140

Development Biotechnology Travel Programming 140

GeekWire

JUNE 17, 2021

Athira Pharma CEO Leen Kawas has been placed on temporary leave until the Seattle area biotechnology company completes a review “stemming from doctoral research Dr. Kawas conducted while at Washington State University.” Athira Pharma CEO Leen Kawas at the 2018 GeekWire Summit. GeekWire Photo / Kevin Lisota).

Biotechnology 120

Biotechnology Journal Research Study 120

GeekWire

MARCH 2, 2021

A few weeks ago, a longtime GeekWire reader sent a note expressing shock that Sana Biotechnology co-founder and CEO Steve Harr only owned 4.9% Given that the Seattle biotechnology company was on the cusp of a blockbuster stock market debut and now is valued at more than $6 billion, I responded that 4.9% ownership prior to the IPO.

Biotechnology 135

Biotechnology Company Examples Financial 135